Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Allard

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Purification of ras GTPase activating protein from bovine brainJ B Gibbs, M D Schaber, W J Allard, et al.
The Journal of Urology|May 24, 2001
Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./mlK Okihara, H A Fritsche, A Ayala, et al.
Journal of Clinical Laboratory Analysis|February 20, 1999
Measurement of four tumor marker antigens in the sera of pregnant womenC D Cheli, D L Morris, I E Neaman, et al.
Cancer Research|March 1, 1994
Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancerW J Allard, I E Neaman, J J Elting, et al.
Urology|September 8, 1998
Measurement of complexed PSA improves specificity for early detection of prostate cancerM K Brawer, G E Meyer, J L Letran, et al.
Science (New York, N.Y.)|September 6, 1985
Sequence and structure of a human glucose transporterM Mueckler, C Caruso, S A Baldwin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Analysis of monoclonal antibodies to prostate-specific antigen: reactivity with native and recombinant prostate-specific antigenZ Zhou, T R Barnett, D L Very, et al.
Anticancer Research|June 9, 2001
Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancerG B Cook, I E Neaman, J L Goldblatt, et al.
The International Journal of Biological Markers|July 10, 1999
Multicenter evaluation of the performance and clinical utility in longitudinal monitoring of the Bayer Immuno 1 complexed PSA assayW J Allard, C D Cheli, D L Morris, et al.
Clinical Chemistry|April 29, 1998
Multicenter evaluation of the Bayer Immuno I CA 15-3 assayC D Cheli, D L Morris, L Kish, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Purification of ras GTPase activating protein from bovine brainJ B Gibbs, M D Schaber, W J Allard, et al.
The Journal of Urology|May 24, 2001
Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./mlK Okihara, H A Fritsche, A Ayala, et al.
Journal of Clinical Laboratory Analysis|February 20, 1999
Measurement of four tumor marker antigens in the sera of pregnant womenC D Cheli, D L Morris, I E Neaman, et al.
Cancer Research|March 1, 1994
Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancerW J Allard, I E Neaman, J J Elting, et al.
Urology|September 8, 1998
Measurement of complexed PSA improves specificity for early detection of prostate cancerM K Brawer, G E Meyer, J L Letran, et al.
Science (New York, N.Y.)|September 6, 1985
Sequence and structure of a human glucose transporterM Mueckler, C Caruso, S A Baldwin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Analysis of monoclonal antibodies to prostate-specific antigen: reactivity with native and recombinant prostate-specific antigenZ Zhou, T R Barnett, D L Very, et al.
Anticancer Research|June 9, 2001
Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancerG B Cook, I E Neaman, J L Goldblatt, et al.
The International Journal of Biological Markers|July 10, 1999
Multicenter evaluation of the performance and clinical utility in longitudinal monitoring of the Bayer Immuno 1 complexed PSA assayW J Allard, C D Cheli, D L Morris, et al.
Clinical Chemistry|April 29, 1998
Multicenter evaluation of the Bayer Immuno I CA 15-3 assayC D Cheli, D L Morris, L Kish, et al.
Pageof 3